BioLineRx (BLRX) Exchange Rate Effect (2013 - 2025)
BioLineRx (BLRX) recorded quarterly Exchange Rate Effect of $125000.0 in Q4 2025, up 68.92% quarter-over-quarter from $74000.0 in Q3 2025, and down 22.84% on a YoY basis from $162000.0 in Q4 2024.
BioLineRx (BLRX) Exchange Rate Effect (2013 - 2025) Analysis & Trends
BioLineRx's Exchange Rate Effect history runs 13 years deep, the most recent figure standing at $125000.0 for Q4 2025.
- In Q4 2025, Exchange Rate Effect fell 22.84% year-over-year to $125000.0; the TTM figure through Dec 2025 stood at $549000.0 (up 2395.45% YoY), while the FY2025 annual figure was $549000.0, up 2395.45% from the prior year.
- Exchange Rate Effect was $125000.0 for Q4 2025 at BioLineRx, up from $74000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $625000.0 in Q2 2022 to a low of -$1.1 million in Q3 2022.
- Historically, Exchange Rate Effect has averaged -$2650.0 across 5 years, with a median of $500.0 in 2022.
- The sharpest annual moves came in 2022 and 2023: Exchange Rate Effect plunged 1621.54% in 2022, then soared 484.0% in 2023.
- A 5-year view of Exchange Rate Effect shows it stood at $244000.0 in 2021, then tumbled by 120.49% to -$50000.0 in 2022, then jumped by 484.0% to $192000.0 in 2023, then declined by 15.62% to $162000.0 in 2024, then dropped by 22.84% to $125000.0 in 2025.
- The last three Exchange Rate Effect figures came in at $125000.0 (Q4 2025), $74000.0 (Q3 2025), and $432000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.60 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -2.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | -40.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 8.68 Mn |
| 10 | BioLineRx | 227.63 Mn | 211.90 Mn | 154,000.00 | 125,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 125,000.00 |
| Dec 31, 2025 | 125,000.00 |
| Sep 30, 2025 | 74,000.00 |
| Sep 30, 2025 | 74,000.00 |
| Jun 30, 2025 | 432,000.00 |
| Jun 30, 2025 | 432,000.00 |
| Mar 31, 2025 | -82,000.00 |
| Mar 31, 2025 | -82,000.00 |
| Dec 31, 2024 | 162,000.00 |
| Dec 31, 2024 | 162,000.00 |
| Sep 30, 2024 | 81,000.00 |
| Sep 30, 2024 | 81,000.00 |
| Jun 30, 2024 | -272,000.00 |
| Jun 30, 2024 | -272,000.00 |
| Mar 31, 2024 | 51,000.00 |
| Mar 31, 2024 | 51,000.00 |
| Dec 31, 2023 | 192,000.00 |
| Dec 31, 2023 | 192,000.00 |
| Sep 30, 2023 | -72,000.00 |
| Sep 30, 2023 | -72,000.00 |